ImmunityBio (IBRX) AI Analysis

IBRX$6.22+0.24 +4.10%
BiotechnologyValue StockGrowth Stock
Compare
Market cap$6.62BEnterprise value$10.20BRevenue (TTM)$165.79MMarket position—

Score

65
Bullish
Value
63
Quality
33
Growth
100

AI Score 30. ImmunityBio, Inc. has a high market cap of approximately $9.46 billion but is facing significant financial challenges, with a net profit margin of -5.99% and a price-to-sales ratio of 57.1, indicating overvaluation relative to its revenue

ImmunityBio (IBRX) AI Analysis

IBRX price $6.22 +0.24 +4.10%

Ticker
IBRX
Price
$6.22
Change
+0.24 +4.10%
Market cap
$6.62B
Forward P/E
11.58
Dividend yield
0.00%
Beta
0.12
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
65
Value
63
Quality
33
Growth
100

Stocklytics score rationale: value 63, quality 33, growth 100.

AI Score 30. ImmunityBio, Inc. has a high market cap of approximately $9.46 billion but is facing significant financial challenges, with a net profit margin of -5.99% and a price-to-sales ratio of 57.1, indicating overvaluation relative to its revenue

Insights · Forecast · Financials · Learn

Stocklytics home · Screener